Vajihe Akbari

1.7k total citations
66 papers, 1.3k citations indexed

About

Vajihe Akbari is a scholar working on Molecular Biology, Biomaterials and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Vajihe Akbari has authored 66 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 15 papers in Biomaterials and 15 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Vajihe Akbari's work include Monoclonal and Polyclonal Antibodies Research (14 papers), Protein purification and stability (8 papers) and Nanoparticle-Based Drug Delivery (8 papers). Vajihe Akbari is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (14 papers), Protein purification and stability (8 papers) and Nanoparticle-Based Drug Delivery (8 papers). Vajihe Akbari collaborates with scholars based in Iran, Canada and Egypt. Vajihe Akbari's co-authors include Fatemeh Hendijani, Daryoush Abedi, Azade Taheri, Mahboubeh Rezazadeh, Abbas Pardakhty, Hojjat Sadeghi‐Aliabadi, Abbas Jafarian‐Dehkordi, C. Perry Chou, D Abedi and Jaleh Varshosaz and has published in prestigious journals such as SHILAP Revista de lepidopterología, PEDIATRICS and Carbohydrate Polymers.

In The Last Decade

Vajihe Akbari

63 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vajihe Akbari Iran 22 585 234 213 187 166 66 1.3k
Laura de Oliveira Nascimento Brazil 18 532 0.9× 186 0.8× 112 0.5× 184 1.0× 120 0.7× 42 1.6k
Sinéad M. Ryan Ireland 21 750 1.3× 277 1.2× 312 1.5× 207 1.1× 169 1.0× 28 1.6k
Paul Baldrick United Kingdom 22 322 0.6× 241 1.0× 91 0.4× 196 1.0× 117 0.7× 59 1.5k
M.E.M. Cruz Portugal 27 752 1.3× 392 1.7× 98 0.5× 363 1.9× 184 1.1× 57 1.9k
Qing Zhao China 25 904 1.5× 142 0.6× 106 0.5× 61 0.3× 120 0.7× 64 1.8k
Xurui Cheng China 7 1.3k 2.3× 133 0.6× 146 0.7× 83 0.4× 107 0.6× 9 2.0k
Philip D. Rye United Kingdom 22 758 1.3× 90 0.4× 101 0.5× 78 0.4× 88 0.5× 59 1.4k
Akihiko Hasegawa Japan 29 536 0.9× 73 0.3× 239 1.1× 205 1.1× 155 0.9× 91 3.2k
Hee Sam Na South Korea 23 584 1.0× 113 0.5× 109 0.5× 83 0.4× 154 0.9× 68 1.5k
Wenjun Zhu China 14 498 0.9× 172 0.7× 136 0.6× 95 0.5× 397 2.4× 24 1.2k

Countries citing papers authored by Vajihe Akbari

Since Specialization
Citations

This map shows the geographic impact of Vajihe Akbari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vajihe Akbari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vajihe Akbari more than expected).

Fields of papers citing papers by Vajihe Akbari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vajihe Akbari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vajihe Akbari. The network helps show where Vajihe Akbari may publish in the future.

Co-authorship network of co-authors of Vajihe Akbari

This figure shows the co-authorship network connecting the top 25 collaborators of Vajihe Akbari. A scholar is included among the top collaborators of Vajihe Akbari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vajihe Akbari. Vajihe Akbari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Varshosaz, Jaleh, et al.. (2023). Anti HER-2 aptamer functionalized gold nanoparticles of dasatinib for targeted chemo-radiotherapy in breast cancer cells. Biomaterials Advances. 154. 213591–213591. 17 indexed citations
2.
Akbari, Vajihe, et al.. (2023). Design and construction of scFv-PE35KDEL as a novel immunotoxin against human epidermal growth factor receptor 2 for cancer therapy. Biotechnology Letters. 45(4). 537–550. 3 indexed citations
3.
Akbari, Vajihe, et al.. (2023). Development of Solubilization and Refolding Buffers. Methods in molecular biology. 2617. 155–164.
4.
5.
Akbari, Vajihe, et al.. (2021). Inhibition of Aldehyde Dehydrogenase by Furazolidone Nanoemulsion to Decrease Cisplatin Resistance in Lung Cancer Cells. Therapeutic Delivery. 12(8). 611–625. 4 indexed citations
6.
7.
Akbari, Vajihe, et al.. (2021). Risk of neurodegenerative disease due to tau phosphorylation changes and arsenic exposure via drinking water. Toxicology Research. 10(2). 325–333. 23 indexed citations
8.
Akbari, Vajihe, et al.. (2021). DFF40-iRGD, a novel chimeric protein with efficient cytotoxic and apoptotic effects against triple-negative breast cancer cells. Biotechnology Letters. 43(10). 1967–1976. 5 indexed citations
9.
Akbari, Vajihe, et al.. (2021). Bioassay-Guided Fractionation and Antimicrobial Activities of Padina australis Extracts. Jundishapur Journal of Natural Pharmaceutical Products. 15(4). 3 indexed citations
10.
Jahanian‐Najafabadi, Ali, et al.. (2020). Optimization of Buffer Additives for Efficient Recovery of hGM-CSF from Inclusion Bodies Using Response Surface Methodology.. Iranian journal of pharmaceutical research. 19(3). 297–309. 2 indexed citations
11.
Rezazadeh, Mahboubeh, Vajihe Akbari, & Zahra Ebrahimi. (2020). Comparison the effects of chitosan and hyaluronic acid-based thermally sensitive hydrogels containing rosuvastatin on human osteoblast-like MG-63 cells. Research in Pharmaceutical Sciences. 15(1). 97–97. 17 indexed citations
12.
Taymouri, Somayeh, et al.. (2019). Biotin decorated sunitinib loaded nanostructured lipid carriers for tumor targeted chemotherapy of lung cancer. Journal of Drug Delivery Science and Technology. 50. 237–247. 19 indexed citations
13.
Minaiyan, Mohsen, et al.. (2019). Nanocrystalline cellulose–hyaluronic acid composite enriched with GM-CSF loaded chitosan nanoparticles for enhanced wound healing. Biomedical Materials. 14(3). 35003–35003. 48 indexed citations
14.
Akbari, Vajihe, et al.. (2018). Improvement of solubility and refolding of an anti-human epidermal growth factor receptor 2 single-chain antibody fragment inclusion bodies. Research in Pharmaceutical Sciences. 13(6). 566–566. 15 indexed citations
15.
16.
Akbari, Vajihe, et al.. (2018). In Vitro Cytotoxic Activity of a Lactococcus lactis Antimicrobial Peptide Against Breast Cancer Cells.. PubMed. 16(3). e1867–e1867. 27 indexed citations
17.
Akbari, Vajihe, et al.. (2017). Preparation and characterization of metformin surface modified cellulose nanofiber gel and evaluation of its anti-metastatic potentials. Carbohydrate Polymers. 165. 322–333. 42 indexed citations
18.
Akbari, Vajihe, et al.. (2017). Anti-tuberculosis and cytotoxic evaluation of the seaweed Sargassum boveanum. Research in Pharmaceutical Sciences. 13(1). 30–30. 10 indexed citations
19.
Akbari, Vajihe, M. Hamid, Abbas Jafarian‐Dehkordi, Daryoush Abedi, & C. Perry Chou. (2015). Improved biological activity of a single chain antibody fragment against human epidermal growth factor receptor 2 (HER2) expressed in the periplasm of Escherichia coli. Protein Expression and Purification. 116. 66–74. 20 indexed citations
20.
Salehi‐Abargouei, Amin, et al.. (2014). Efficacy and Safety of Saccharomyces boulardii for Acute Diarrhea. PEDIATRICS. 134(1). e176–e191. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laura de Oliveira Nascimento Breakdown of academic impact, for papers by Sinéad M. Ryan Breakdown of academic impact, for papers by Paul Baldrick Breakdown of academic impact, for papers by M.E.M. Cruz Breakdown of academic impact, for papers by Qing Zhao Breakdown of academic impact, for papers by Xurui Cheng Breakdown of academic impact, for papers by Philip D. Rye Breakdown of academic impact, for papers by Akihiko Hasegawa Breakdown of academic impact, for papers by Hee Sam Na Breakdown of academic impact, for papers by Wenjun Zhu
Rankless by CCL
2026